OGC
ALDX icon

One68 Global Capital’s Aldeyra Therapeutics ALDX Stock Holding History

One68 Global Capital’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$123K Buy
+17,899
New +$126K 0.25% 95

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

One68 Global Capital's ALDX Position: Q4 2020 in Review

One68 Global Capital opened a new position in Aldeyra Therapeutics (ALDX) in Q4 2020: 17,899 shares worth $123K. The stake represents 0.25% of the portfolio and ranks #95 among its holdings.

98 funds tracked by Wall St. Rank hold ALDX as of Q4 2020.

  • One68 Global Capital held 17,899 shares of Aldeyra Therapeutics worth $123K as of Q4 2020.
  • Aldeyra Therapeutics was a new One68 Global Capital position in Q4 2020.
  • Aldeyra Therapeutics made up 0.25% of One68 Global Capital's portfolio in Q4 2020, its #95 holding.
  • 98 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.